Table 1 Evidence from clinical and preclinical studies (clinical studies). Clinical trial Condition No. of patients Study design Treatment Control Duration Outcome Sign for grading evidence 1À
212
Grading of evidence suggesting serratiopeptidase as anti-in ammatory agent Esch et al. Postoperative and 66 Randomised 19894 traumatic swelling (repair of lateral collateral ligament of knee) Postoperative and 98/group in two Randomised and Tsuyama traumatic swelling drug groups and 99 double blind et al.13 in placebo group Tachibana Postoperative buccal 174 (88 in TSP and Multicentre, et al. 198414 swelling 86 in placebo group) randomised, (Caldwell-luc double blind, antrotomy) placebo-controlled Super cial 40 (20 per group) Randomised Bracale 15 thrombophlebitis et al. 1996
Serratiopeptidase: dos
e not speci ed
Application of ice, leg elevation and bed rest
Unclear
Reduction in swelling by 50% on third postoperative day and pain disappeared by 10th day in TSP group A-4700 shown to be equally effective to Serratiopeptidase in improving symptoms and reducing swelling Buccal swelling reduced signi cantly in serratiopeptidase group 65% of TSP while 85% cases of SAP showed improvement in speci c symptoms like pain, erythema Moderate to marked improvement in breast pain, swelling and induration seen in TSP group Clinical improvement seen in 65% patients
Serratiopeptidase: dose not speci ed
A-4700 tablet and Placebo
Not stated
1À
Serratiopeptidase 10 mg thrice daily (30mg/day) Serratiopeptidase 10 mg thrice daily (30mg/day) Serratiopeptidase: 10mg thrice daily (30 mg/day) Serratiopeptidase: 10 mg twice daily with initial short course of nimesulide e
Placebo
7 days
1þ
S. Bhagat et al./ International Journal of Surgery 11 (2013) 209e217
Seaprose S (SAP) 30 mg thrice daily (90mg/day) Placebo
14 days
1þ
Kee et al. 19895
Breast engorgement
70 (35 per group)
Randomised, double blind
3 days
1þ
REVIEW
Panagariya et al. 19997
Carpel tunnel syndrome
20 patient
Prospective trial
e
6 weeks
2À
e
Back pain, migraine
No randomised controlled trials
e
e
e
e
e
Grading of evidence for its use in otorhinolaryngology pathologies Acute or chronic ear, 193 (about 96 per Mazzone nose or throat disorder group) et al. 19901
Multicentre, randomised, double blind, placebo-controlled
Serratiopeptidase (2 tablets of 5 mg) thrice daily, i.e., 30 mg/day
Placebo (2 tablets thrice daily)
7e8 days
Bellussi et al. 1984
Secretory otitis media 16
75
Nagaoka et al. 197917
Chronic respiratory disease with dif cult in expectoration Chronic respiratory disease (not bronchial asthma) Chronic sinusitis
Shimura et al. 198318 Majima et al. 198819
376 patients (125 in Seaprose S, 128 in TSP and 123 in placebo group) 40 (<10/group)
Randomised and double blind (for 50 patients) Multicentre, randomised, double-blind, double dummy Randomised
Serratiopeptidase (0.5 mg/kg/day) Serratiopeptidase (10 mg thrice daily)
Placebo
10 days
Seaprose S (15 mg thrice daily) and placebo
14 days
Serratiopeptidase 30 mg/day Serratiopeptidase 30 mg/day
e
Prospective, open label
Various mucolytic agents as comparator e
7 days
TSP showed good ef cacy in reducing symptoms like severity of pain, amount and purulence of secretions, dif culty in swallowing, nasal dysphonia and obstruction and anosmia Unde ned global judgement Numerous tests but outcomes unclear No signi cant difference between two groups in showing improvement in expectoration and speci c symptoms Relaxation of sputum viscoelasticity TSP reduced the viscosity of mucus but not its elasticity
1þ
1À
1þ
1À
4weeks
2À

evidence in making decisions about the care of individual?patients.(Sackett,?DL)? ? A systematic review is a comprehensive study of A?systematic?review?...
The_Level_of_Evidence_Pyramid__Indicating_Levels.47_临床医学_医药卫生_专业...a systematic review of these studies Case-control study; or any of the ...
-aventis Second edition Evidence-based medicine What is a systematic review?...existing agendas have failed to address a clinical problem G Increasingly ...
(Lepidium meyenii) for treatment of menopausal symptoms A systematic review_... a qualitative review and opted for a synthesis of the best evidence. ...
A Systematic Review of Xuezhikang, for Coronary Heart Disease Complicated by... Hindawi Publishing Corporation Evidence-Based Complementary and Alternative ...
of Findings table for a Cochrane systematic review_经济学_高等教育_教育专区...GRADE of the quality of evidence (last column and footnotes of the SoF)...
provide stronger evidence than a ‘higher level’ study – say a systematic review of few studies leading to an inconclusive result (see Background ...
we performed a systematic review and meta-analysis of the current evidence for the association between ALA exposure, including studies of dietary ALA and ...
systematic reniew and meta-analysis of the effects of high protein oral ...The systematic review and meta-analysis provides evidence that high protein ...
It may provide bene?ts and clinical evidence for both patients and clinicians. Although a related systematic review has been published by Hao and ...
热门文档